News
February 15, 2017
June 6, 2023
Revolutionary AI Harnesses the Power of Human Intuition in Core Technologies
November 2, 2021
KIBIT Automator, an AI-based e-discovery and digital forensics platform, runs on Microsoft Azure, the world's most secure environment.
December 6, 2022
NEW YORK, December 6, 2022 – FRONTEO (TSE: 2158) has announced it has developed a new core algorithm for its AI review tool, "KIBIT Automator".
April 4, 2023
FRONTEO changes AI engine and product names to strengthen brand power and promote market penetration
February 6, 2024
Enhanced function of the Drug Discovery AI Factory, analyze cutting-edge academic articles to propose highly novel target molecules and hypotheses
January 16, 2023
NEW YORK, January 16, 2023 – FRONTEO (TSE: 2158) has announced today that its proprietary AI engine "KIBIT" has successfully improved Japanese language processing in natural language processing.
March 14, 2019
May 6, 2020
February 29, 2024
FRONTEO, Inc. (Headquarters: Minato-ku, Tokyo; President & CEO: Masahiro Morimoto) is hosting a free seminar “Recent Developments in AI and Competition Law – a Global Perspective” in collaboration with White & Case LLP on March 19th.
July 28, 2021
By building KIBIT Automator on a cloud environment, we will create a highly reliable service platform that meets a large amount of data processing demand, improve data analysis efficiency, and reduce man-hours and costs.
January 28, 2025
Accelerate First in Class R&D with FRONTEO’s unique technologies that systematically discover unreported relationships between diseases and molecules from existing literature information.
April 30, 2021
Expanded the functions of the AI review tool “KIBIT Automator” which is a key to FRONTEO’s portfolio transformation, enabling one-stop handling of eDiscovery process from pre-processing to document review.
June 27, 2023
NEW YORK, June 27, 2023 – FRONTEO (TSE: 2158) is pleased to announce it has developed a new technology that analyzes hashed data (patent pending) with its in-house developed AI engine "KIBIT".
January 16, 2025
FRONTEO’s Drug Discovery AI Factory, an AI drug discovery service using unique technologies that discover unreported relationships from published literature, to support target identification and drug repositioning etc.
January 12, 2024
FRONTEO is a proud sponsor of Legalweek 2024 at the New York Hilton Midtown – January 29th – February 1st. Come join your peers in the legal profession at this annual gathering.
January 8, 2019
February 15, 2024
Tokyo, Japan, February 14, 2024 – FRONTEO, Inc. (Head Office: Tokyo, Japan; Chief Executive Officer: Masahiro Morimoto; hereafter "FRONTEO") and Shionogi Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi; hereafter "Shionogi") are pleased to announce that we have entered into a strategic business partnership agreement for the dementia-related AI program and depression-related AI program.
April 4, 2023
FRONTEO Will Discuss Leveraging AI in Cross-Border Forensics